ETI
NVO

Enterprise Trust & Investment’s Novo Nordisk NVO Stock Holding History

Enterprise Trust & Investment’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-356
Closed -$12K – 216
2021
Q1 		$12K Hold
356
– – 0.01% 165
2020
Q4 		$12K Hold
356
– – 0.01% 168
2020
Q3 		$12K Hold
356
– – 0.01% 166
2020
Q2 		$12K Hold
356
– – 0.01% 160
2020
Q1 		$11K Hold
356
– – 0.01% 151
2019
Q4 		$10K Hold
356
– – 0.01% 164
2019
Q3 		$9K Hold
356
– – 0.01% 175
2019
Q2 		$9K Buy
+356
New +$8.8K 0.01% 160

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Enterprise Trust & Investment's NVO Position: Q2 2021 in Review

Enterprise Trust & Investment sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 356 shares — an estimated $12K sold.

Enterprise Trust & Investment first reported a position in NVO in Q2 2019 and held it in 8 quarters. The position peaked at $12K in Q1 2021. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Enterprise Trust & Investment reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Enterprise Trust & Investment sold 356 Novo Nordisk shares in Q2 2021, an estimated $12K.
  • Enterprise Trust & Investment first reported a position in Novo Nordisk in Q2 2019 and held it in 8 quarters.
  • Enterprise Trust & Investment's Novo Nordisk position peaked at $12K in Q1 2021.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Enterprise Trust & Investment's 13F filing for Q2 2021, filed 12 Jul 2021.